◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.

CIK: 1350156 SIC: 5700
-
Revenue
$-906.89K
Net Income
-
Gross Margin
-
Op. Margin
$-76.26K
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 12 of 43 quarterly reports available
Breakdown Q1 2026
(Aug 31, 2025)
Q3 2025
(Feb 28, 2025)
Q2 2025
(Nov 30, 2024)
Q1 2025
(Aug 31, 2024)
Q4 2024
(May 31, 2024)
Q3 2024
(Feb 29, 2024)
Q2 2024
(Nov 30, 2023)
Q1 2024
(Aug 31, 2023)
Q4 2023
(May 31, 2023)
Q3 2023
(Feb 28, 2023)
Q2 2023
(Nov 30, 2022)
Q1 2023
(Aug 31, 2022)
+ Total Revenue - - - - - - - - - - - -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Cost of Revenue - - - - - - - - - - - -
+ Gross Profit - - - - - - - - - - - -
Gross Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $875.20K $13.46K $13.67K $4.63K $4.61K $8.81K $45.11K $40.92K $37.34K $36.49K $45.09K $37.35K
Research & Development $391.26K - - - $-504.00 $2.44K $2.18K $1.52K $1.31K $371.00 $1.57K $3.27K
+ Operating Income $-875.20K - $-13.67K $-4.63K $-4.61K $-8.81K $-45.11K $-40.92K $-37.34K $-36.49K $-45.09K $-37.35K
Operating Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Interest Expense $13.00 - - - - - - - - - - -
Income Before Tax - $-13.46K - - - - - - - - - -
Income Tax Expense - - - - - - - - - - - -
+ Net Income $-875.13K $-13.46K $-13.67K $-4.63K $-4.61K $-8.81K $-45.11K $-40.92K $-37.34K $-36.49K $-45.09K $-37.35K
Net Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Basic EPS -0.04 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 nan nan nan
Diluted EPS -0.04 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 nan nan nan
Basic Shares Outstanding 19.8M 19.8M 19.8M 19.8M - 19.8M 19.8M 19.8M - - - -
Diluted Shares Outstanding 19.8M 19.8M 19.8M 19.8M - - 19.8M 19.8M - - - -
Breakdown Q1 2026
(Aug 31, 2025)
Q3 2025
(Feb 28, 2025)
Q2 2025
(Nov 30, 2024)
Q1 2025
(Aug 31, 2024)
Q4 2024
(May 31, 2024)
Q3 2024
(Feb 29, 2024)
Q2 2024
(Nov 30, 2023)
Q1 2024
(Aug 31, 2023)
Q4 2023
(May 31, 2023)
Q3 2023
(Feb 28, 2023)
Q2 2023
(Nov 30, 2022)
Q1 2023
(Aug 31, 2022)
Cash & Cash Equivalents $130.28K $3.00 $165.00 $1.00 $14.00 $1.19K $1.87K $355.00 $6.00 $32.00 $175.00 $200.00
Total Current Assets $490.29K $3.00 $165.00 $1.00 $14.00 $1.19K $1.87K $355.00 $6.00 $32.00 $175.00 $200.00
Total Assets $1.15M $3.00 $165.00 $1.00 $14.00 $1.19K $1.87K $355.00 $6.00 $32.00 $175.00 $200.00
Short-term Debt $89.78K - - - - - - - - - - -
Other Current Liabilities - $191.33K $191.33K $191.33K $191.33K $191.33K $191.33K - $134.79K $134.79K $134.79K $134.79K
Total Current Liabilities $722.96K $2.43M $2.41M $2.40M $2.40M $2.39M $2.38M $2.34M $2.30M $2.26M $2.22M $2.18M
Total Liabilities $722.96K $2.43M $2.41M $2.40M $2.40M $2.39M $2.38M $2.34M $2.30M $2.26M $2.22M $2.18M
Common Stock $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K $19.77K
Retained Earnings $-6.09M $-5.16M $-5.15M $-5.13M $-5.13M $-5.12M $-5.11M $-5.07M $-5.03M $-4.99M $-4.96M $-4.91M
Total Stockholders Equity $427.32K $-2.43M $-2.41M $-2.40M $-2.40M $-2.39M $-2.38M $-2.34M $-2.30M $-2.26M $-2.22M $-2.18M
Total Liabilities & Equity $1.15M $3.00 $165.00 $1.00 $14.00 $1.19K $1.87K $355.00 $6.00 $32.00 $175.00 $200.00
Breakdown Q1 2026
(Aug 31, 2025)
Q3 2025
(Feb 28, 2025)
Q2 2025
(Nov 30, 2024)
Q1 2025
(Aug 31, 2024)
Q4 2024
(May 31, 2024)
Q3 2024
(Feb 29, 2024)
Q2 2024
(Nov 30, 2023)
Q1 2024
(Aug 31, 2023)
Q4 2023
(May 31, 2023)
Q3 2023
(Feb 28, 2023)
Q2 2023
(Nov 30, 2022)
Q1 2023
(Aug 31, 2022)
Net Income $-875.13K $-31.76K $-18.29K $-4.63K $-4.61K $-8.81K $-45.11K $-40.92K $-37.34K $-118.93K $-82.44K $-37.35K
Change in Payables $-12.33K - - - - - - - - - - -
Operating Cash Flow $-74.80K $387.00 $549.00 $-2.40K $-3.63K $-27.25K $-23.70K $-13.60K $-5.66K $-31.95K $-24.01K $-13.29K
Investing Cash Flow - - - - - - - - - - - -
Financing Cash Flow $204.86K $-398.00 $-398.00 $2.38K $2.44K $28.44K $25.57K $13.95K $5.64K $31.73K $23.93K $13.23K
Net Change in Cash $130.28K - - - - - - - - - - -
SEC Filing Format - Data shown as it appears in the Q1 2026 (10-Q) filing Period ended: Aug 31, 2025
Condensed Consolidated Statements of Operations
Description Aug 31, 2025
Current Prior Year
Total Revenue - -
Operating Expenses $875.20K $4.63K
Research & Development $391.26K -
Operating Income $-875.20K $-4.63K
Interest Expense $13.00 -
Income Tax Expense - -
Net Income $-875.13K $-4.63K
Basic EPS -0.04 0.00
Diluted EPS -0.04 0.00
Basic Shares Outstanding $19.77M $19.77M
Diluted Shares Outstanding $19.77M $19.77M
Condensed Consolidated Balance Sheets
Description Aug 31, 2025 May 31, 2025
Cash & Cash Equivalents $130.28K -
Total Current Assets $490.29K -
Total Assets $1.15M -
Short-term Debt $89.78K $201.33K
Other Current Liabilities - $10.00
Total Current Liabilities $722.96K $2.34M
Total Liabilities $722.96K $2.34M
Common Stock $19.77K $19.77K
Retained Earnings $-6.09M $-5.21M
Total Stockholders Equity $427.32K $-2.34M
Total Liabilities & Equity $1.15M -
Condensed Consolidated Statements of Cash Flows
Description Aug 31, 2025
Current Prior Year
Net Income $-875.13K $-4.63K
Change in Payables $-12.33K $2.23K
Operating Cash Flow $-74.80K $-2.40K
Investing Cash Flow - -
Financing Cash Flow $204.86K $2.38K
Net Change in Cash $130.28K $-13.00

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...